Positron Corporation

POSC ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $-10.6M $-2.4M $-2.6M $-7.1M $-8.0M $-6.1M $-10.9M
Depreciation & Amortization — — $152.0K $160.0K $226.0K $77.0K $43.0K
Depreciation $27.4K $22.1K — — — — —
Amortization — — — — — — —
Stock-Based Compensation $5.0M — $89.0K $656.0K $1.8M $0 $2.5M
Net Cash from Operating Activities $-4.7M $-1.7M $-2.4M $-3.0M $-2.2M $-4.1M $-4.7M
Investing Activities
Capital Expenditures — — $26.0K $16.0K $73.0K $10.0K $238.0K
Business Acquisitions — — — $0 $-1.0K $0 —
Net Cash from Investing Activities $-99.0K — — $-16.0K $-72.0K $-10.0K $-238.0K
Financing Activities
Dividends Paid — — — — — — —
Stock Repurchases — — — — — — —
Net Cash from Financing Activities $7.3M $1.7M — $4.6M $2.6M $2.9M $5.9M
Net Change in Cash $2.5M $-30.9K $-1.5M $1.5M $242.0K $-1.1M $976.0K
Free Cash Flow — — $-2.4M $-3.1M $-2.3M $-4.1M $-4.9M